Culture

The role of nanobacteria in the organic matter cycle in freshwater systems

Because of their small size, some microorganisms can come through the pores of bacterial filters. Such filtrable microorganisms are difficult to grow in lab conditions and therefore remain understudied. Scientists believe that filtrable microorganisms are widely spread in the biosphere and participate in many biogeochemical processes, such as the restoration of sulfur in deep-see regions. They also play an important role in the production and use of dissolved organic matter. This term refers to a group of compounds (such as amino acids, organic acids and monomeric sugars) that are easily utilizable sources of nutrients in freshwater systems.

These compounds occur in pristine lotic systems at very low concentrations mainly from primary producers (photosynthetic bacteria or algae) or from land runoffs, wastewater discharges, and are consumed by heterotrophic microorganisms (i.e. the microorganisms that are unable to synthesize organic matter from inorganic carbon). Therefore, it is important to understand the major microbial groups and environmental factors important for the transformation of organic compounds at natural, very low (nanomolar) concentrations.

A team of researchers from Immanuel Kant Baltic Federal University, the Kurchatov Institute, and the Winogradsky Institute of Microbiology together with their colleagues from the UK, and Spain, participated in the study led by Bangor University (UK) on the taxonomic composition and functional characteristics of filtrable freshwater organisms, as well as their contribution to the carbon cycle. To do so, they compared the samples of unfiltered and filtered water from the River Conwy (UK). In their experiment, the team used radioisotope tracers (radiolabelled organic substrates) and targeted metabolomics (mass-spectrometry) to measure substrates' uptake and respiration alongside the molecular analysis of microbial DNA to identify major microbial groups.

"Based on the results of the study, we concluded that filtrable fraction of microorganisms has a lower efficiency than the microbial community as a whole, and play a minor role in the processing of dissolved organic carbon. Moreover, their role in the system is further reduced because they have only a limited time to uptake dissolved organic matter in rivers and streams," explained Evgenii Lunev, a co-author of the work.

Credit: 
Immanuel Kant Baltic Federal University

Hidden conflict in the mutually beneficial relationship between legumes and rhizobia

image: A cluster of nodules on the roots of the plant Lotus japonicus. Bacterial rhizobia are housed within root nodules and supplied with carbohydrates from the host plant. The carbohydrates are used by rhizobia in exchange for the fixation of nitrogen then used by the plant.

Image: 
K. Quides

Orange, Calif. - The mutually beneficial relationship between legumes and rhizobia, the nitrogen-fixing soil bacteria that make their home in legume root nodules and create nutrient-rich fertilizer for them, is one of the most well-known and agronomically important examples of symbiosis. New research from Dr. Kenjiro Quides, a Postdoctoral Teaching and Research Fellow in the Grand Challenges Initiative at Chapman University, tested the boundaries of this relationship -- and found that it's not always as perfectly harmonious as previously thought.

The results are reported in a new paper in the journal Evolution.

Legumes provide carbohydrates for rhizobial bacteria that live in root nodules, while the rhizobia fix atmospheric nitrogen into a form that's usable for the legume (nitrogen is often a limiting nutrient for plants). In theory, if legumes have greater root nodule growth, they should be able to host more rhizobia, which should produce more nitrogen and enable larger plant growth in general.

The research, carried out by Quides and colleagues at UC Riverside during his doctorate, tested the relationship between root nodule growth and rhizobia using a smaller relative of Soybeans, named Lotus japonicus. By using multiple genetic variants that formed a low, medium, and high number of nodules, the study showed that legumes grew to maximum size when a low and medium number of nodules formed, but legumes that formed a high number of nodules had drastically reduced growth.

The investigation then turned to the rhizobia. The size of the rhizobial population, a standard measure of bacterial growth, was found to continue to increase as the number of nodules formed increased. This suggests a hidden conflict in the symbiotic relationship. It seems that the legume and rhizobia interests are only aligned until the host optimum is reached, a point at which their interests diverge. This provides support for the conclusion that in the symbiotic relationship, rhizobia have an evolutionary advantage.

The results demonstrate that to avoid conflict in symbiotic relationships, hosts must tightly regulate their investment into symbiotic organs (like legumes' root nodules) to maximize their own benefit-to-cost ratio of associating with their symbiotic partner.

"Legumes seem to play a balancing act to maximize their growth, but rhizobia continue to grow and that is a really exciting result," Dr. Quides said.

He noted that this study opens the door to more research. "Although we found diminishing returns for the host from nodulation, the fact that rhizobia population size continued to increase is promising. We found the costs outweigh the benefits at high nodule numbers. However, if we can increase the number of nodules and therefore the rhizobia population size while minimizing the cost to the plant, we have the potential to increase the productivity of legume crops in the future."

Credit: 
Chapman University

Study finds U.S. first responders have mixed feelings about COVID-19 vaccine

Firefighters and emergency medical services workers are at high risk of exposure to COVID-19 while on the job and pose an additional risk of transmitting the virus to others. Although vaccines are a promising public health tool for reducing COVID-19 transmission, little has been known about the perceptions of the COVID-19 vaccine among first responders.

To provide insight, a University of Miami Miller School of Medicine-led study queried a national sample of U.S. firefighters and emergency medical services workers through an anonymous online survey. The study results, published online Feb. 1 in the Journal of Occupational and Environmental Medicine, revealed that more than half of the first responders who replied were uncertain about or reported low acceptance of the vaccine.

"Through the national sample of firefighters and emergency medical services workers, we gained insight into the workforce's hesitancy about the COVID-19 vaccine," said study lead and senior author Alberto J. Caban-Martinez, D.O., Ph.D., M.P.H., associate professor of public health sciences in the Division of Environment & Public Health at the Miller School. "We can leverage this study's information to design workplace interventions that educate and encourage our first responders to receive the COVID-19 vaccine."

Demographics determine perceptions

Of the 3,169 respondents to the survey, 48.2% expressed high acceptability of the COVID-19 vaccine, 24.2% were unsure, and 27.6% reported low acceptability. The results also revealed key demographic characteristics -- such as age, race, ethnicity, education, marital status, and job ranking -- for each group of respondents.

Additionally, across all ten geographic regions of the Federal Emergency Management Agency, the southeast (43.1%), the southwest (32.7%) and the west (34.1%) had the highest proportion of first responders who showed low COVID-19 vaccine acceptability.

"An important predictor we discovered from our study was that first responders who had not reported receipt of the influenza vaccine in the prior season had higher odds of being unsure about or not wanting to receive the COVID-19 vaccine," Dr. Caban-Martinez said.

In the study, the co-authors note the importance of tailoring public health campaigns for educating those sub-groups of firefighters and emergency medical service workers who identified as unsure or expressed low COVID-19 acceptability.

Credit: 
University of Miami Miller School of Medicine

Researchers release analysis of largest, most diverse genetic data set

Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority populations. The early analysis, part of a large-scale program funded by the National Heart, Lung, and Blood Institute, examines one of the largest and most diverse data sets of high-quality whole genome sequencing, which makes up a person's DNA. It provides new genetic insights into heart, lung, blood and sleep disorders and how these conditions impact people with diverse racial and ethnic backgrounds, who are often underrepresented in genetic studies.

[Link to study: https://www.nature.com/articles/s41586-021-03205-y]

The program, called Trans-Omics for Precision Medicine (TOPMed), seeks to understand the genetic variations that occur among individuals both in nuclear families and in populations from diverse ethnicities residing on different continents. The project's ultimate goal is to improve the diagnosis, treatment and prevention of the most common conditions that lead to disability or death.

"We have already identified some surprising new insights," said study corresponding author Timothy O'Connor, PhD, Associate Professor of Medicine & Endocrinology at the Institute for Genome Sciences (IGS) at UMSOM. For example, the team identified more than 400 million genetic variations, but 97 percent of them are extremely rare, occurring in less than 1 percent of the population. Gene variations or variants can occur by random chance when genes get recombined or mutate.

"Most of the time, these variants mean nothing," said Dr. O'Connor, "but they can provide a new understanding of mutational processes and recent human evolutionary history."

The TOPMed team includes more than 180 researchers from leading institutions in genomics worldwide who have been compiling huge datasets in systematic and defined ways to increase knowledge about diversity in genetic studies. Since its launch in 2014, the TOPMed investigators have begun adding whole genome sequencing and "omics" analysis (which includes a study of genetic and molecular profiles like proteins) to research studies in order to better understand how variations affect different organ systems giving rise to disease in, for example, the heart and lungs.

In the new Nature paper, the researchers pointed out that the program "aims to identify causal genetic variants and how they interact with the environment, to characterize disease and its molecular subtypes, to understand differences in disease across diverse ancestries, and to establish a foundation for personalized disease prediction, prevention, diagnosis, and treatment." Braxton Mitchell, PhD, Professor of Medicine at UMSOM, and Jeffrey O'Connell, PhD, Associate Professor of Medicine at UMSOM, were co-authors on this paper.

TOPMed is the largest sequencing project to date and has identified over 400 million gene variants with an overarching mission of understanding global genetic diversity. Since joining the TOPMed program in 2016, UMSOM researchers have published valuable new insights on genetic diversity including sequencing data from the initial flagship paper on the first 53,831 TOPMed samples.

The increasing diversity of the population samples will help investigators learn more about how specific diseases impact different ethnic populations around the world. In addition, the group has established uniform standards for sequencing performed on a massive scale. The standards maximizes the integrity of the data as the large group of international researchers use uniform methods as they continue to add other "omics" methods for analysis such as the study of metabolic differences.

In addition to enabling detailed analysis of the combined genomic and health data for sequenced samples, TOPMed has enhanced the analyses of genotyped samples through a new reference panel that now includes over 97,000 individuals. The TOPMed imputation reference panel is publicly available for review and input of new genetic data by researchers.

The first stage of the data release in the Nature study demonstrated a greater inclusion of a diversity of sampling, which will be invaluable to the international group to learn more about the diseases impacting these populations. Because of the vast sample sizes and the longitudinal scope of many of the population samples, the investigators were able to demonstrate that the rare variants represent recent and potentially deleterious changes that can impact protein function, gene expression or other biologically important elements.

"This is a major effort to rectify the underrepresentation of minority participants in genomic studies and tracks with a broader mission within the School of Medicine to increase diversity in clinical trials," said E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. "This will hopefully move the genomics field closer to extending personalized medicine for all patients."

Cashell Jaquish, Ph.D., an NHLBI program officer for TOPMed and a corresponding author on the Nature paper, agrees. "The NHLBI's TOPMed program is a huge resource for the scientific community. We didn't really know what genomic variation looked like in diverse groups until now. This new study represents truly historic findings and we look forward to continued research studies in this area as we move toward personalized medicine."

Credit: 
University of Maryland School of Medicine

'Farfarout'! Solar system's most distant planetoid confirmed

image: Solar System distances to scale, showing the newly discovered 2018 AG37, nicknamed "Farfarout," compared to other known Solar System objects, including the previous record holder 2018 VG18 "Farout", also found by the same team.

Image: 
Roberto Molar Candanosa, Scott S. Sheppard (Carnegie Institution for Science) and Brooks Bays (University of Hawai?i)

A team, including an astronomer from the University of Hawai?i Institute for Astronomy (IfA), have confirmed a planetoid that is almost four times farther from the Sun than Pluto, making it the most distant object ever observed in our solar system. The planetoid, nicknamed "Farfarout," was first detected in 2018, and the team has now collected enough observations to pin down the orbit. The Minor Planet Center has now given it the official designation of 2018 AG37.

Farfarout's name distinguished it from the previous record holder "Farout," found by the same team of astronomers in 2018. The team includes UH Mānoa's David Tholen, Scott S. Sheppard of the Carnegie Institution for Science, and Chad Trujillo of Northern Arizona University, who have an ongoing survey to map the outer solar system beyond Pluto.

Journey around the Sun

Farfarout's current distance from the Sun is 132 astronomical units (au); 1 au is the distance between the Earth and Sun. For comparison, Pluto is only 34 au from the Sun. The newly discovered object has a very elongated orbit that takes it out to 175 au at its most distant, and inside the orbit of Neptune, to around 27 au, when it is closest to the Sun.

Farfarout's journey around the Sun takes about a thousand years, crossing the giant planet Neptune's orbit every time. This means Farfarout has probably experienced strong
gravitational interactions with Neptune over the age of the solar system, and is the reason why it has such a large and elongated orbit.

"A single orbit of Farfarout around the Sun takes a millennium," said Tholen. "Because of this long orbital period, it moves very slowly across the sky, requiring several years of observations to precisely determine its trajectory."

Discovered on Maunakea

Farfarout will be given an official name after its orbit is better determined over the next few years. It was discovered at the Subaru 8-meter telescope located atop Maunakea in
Hawai?i, and recovered using the Gemini North and Magellan telescopes in
the past few years to determine its orbit based on its slow motion across the sky.

Farfarout is very faint, and based on its brightness and distance from the Sun, the team estimates its size to be about 400 km across, putting it on the low end of being a dwarf planet, assuming it is an ice-rich object.

"The discovery of Farfarout shows our increasing ability to map the outer solar system and observe farther and farther towards the fringes of our solar system," said Sheppard. "Only with the advancements in the last few years of large digital cameras on very large telescopes has it been possible to efficiently discover very distant objects like Farfarout. Even though some of these distant objects are quite large, being dwarf planet in size, they are very faint because of their extreme distances from the Sun. Farfarout is just the tip of the iceberg of solar system objects in the very distant solar system."

Interacting with Neptune

Because Neptune strongly interacts with Farfarout, its orbit and movement cannot be used to determine if there is another unknown massive planet in the very distant solar system, since these interactions dominate Farfarout's orbital dynamics. Only those objects whose orbits stay in the very distant solar system, well beyond Neptune's gravitational influence, can be used to probe for signs of an unknown massive planet. These include Sedna and 2012 VP113, which, although they are currently closer to the Sun than Farfarout (at around 80 au), they never approach Neptune and thus would be most influenced by the possible Planet X instead.

"Farfarout's orbital dynamics can help us understand how Neptune formed and evolved, as Farfarout was likely thrown into the outer solar system by getting too close to Neptune in the distant past," said Trujillo. "Farfarout will likely interact with Neptune again since their orbits continue to intersect."

Credit: 
University of Hawaii at Manoa

COVID-related depression linked to reduced physical activity

The United States spends more than $200 billion every year in efforts to treat and manage mental health. The onset of the coronavirus pandemic has only deepened the chasm for those experiencing symptoms of depression or anxiety. This breach has also widened, affecting more people.

New research from Carnegie Mellon University, University of Pittsburgh and University of California, San Diego found that 61% of surveyed university students were at risk of clinical depression, a value twice the rate prior to the pandemic. This rise in depression came alongside dramatic shifts in lifestyle habits.

The study documents dramatic changes in physical activity, sleep and time use at the onset of the COVID-19 pandemic. Disruptions to physical activity emerged as a leading risk factor for depression during the pandemic. Importantly, those who maintained their exercise habits were at significantly lower risk than those who experienced the large declines in physical activity brought on by the pandemic. While physical activity resumed in early summer, mental well-being did not automatically rebound. The results of the study are available online in the February 10 issue of the Proceedings of the National Academy of Sciences.

"There is an alarming rise in the rate of anxiety and depression among young adults, especially among college students," said Silvia Saccardo, assistant professor in the Department of Social and Decision Sciences at CMU and senior author on the paper. "The pandemic has exacerbated the mental health crisis in this vulnerable population."

Saccardo and her colleagues, Osea Giuntella, Kelly Hyde and Sally Sadoff, examined data gathered from 682 college students who used a smartphone app and a Fitbit wearable tracker for spring 2019, fall 2019 and spring 2020. Their results show large disruptions in physical activity, sleep and computer/phone screen time and social interaction, alongside large declines in well-being. This data set spans the onset of social isolation during the early months of the pandemic, offering an insight into the factors that exacerbated mental health disorders in this age group.

"We used this unique dataset to study what factors are predictive of changes in depression," said Saccardo. "[In the dataset,] we can see that mental health gets worse as the semester progresses, but it is dramatically worse in 2020 compared to the previous cohort."

The team found that participants who maintained healthy habits prior to the pandemic -- scheduled physical active and an active social life -- were at a higher risk for depression as the pandemic continued. The researchers point to a decline in physical activity as the leading risk factor for diminished mental health. However, restoration of physical activity was not met with a rebound in mental well-being.

"We randomized a group of individuals to receive incentive to exercise. While our short intervention increased physical activity among this group, it did not have an impact on mental health. These results open up a lot of opportunities for future research," said Saccardo. "It is an interesting puzzle for future studies to understand why we do not see a symmetric relationship between the resumption of physical activity and mental health."

This research documents how COVID-19 has generated large disruptions in mental well-being among college students, a vulnerable population.

"The results are generalizable to the young adult population, a highly exposed group which has exhibited rising depression rates over the last decades and was dramatically exposed to the disruptions caused by the current epidemic," said Giuntella, assistant professor of economics at Pitt. "We need more work to understand whether similar trends were observed in other age groups."

Credit: 
Carnegie Mellon University

Caution: 1918 influenza provides warning for potential future pandemic reemergence

image: This graph shows the four distinct waves. Wave #1 March 1918 (Spring 1918 Wave), #2 October 1918 (Fall 1918 Wave), #3 December 1918 (Winter 1918 Wave) and #4 February 2020 (Winter 1920 Wave)

Image: 
Siddarth Chandra

EAST LANSING, Mich. - The 1918 influenza pandemic provides a cautionary tale for what the future may hold for COVID-19, says a Michigan State University researcher.

After a decade studying a flu virus that killed approximately 15,000 Michigan residents, Siddharth Chandra, a professor in MSU's James Madison College, saw his research come to life as he watched the spread of the COVID-19 pandemic.

"It was so surreal," said Chandra, who has a courtesy appointment in epidemiology and biostatistics. "All of a sudden, I was living my research."

Chandra's research is published in the American Journal of Public Health with co-authors Julia Christensen, a graduate of James Madison College; Madhur Chandra, Senior Community Epidemiologist with the Ingham County Health Department and graduate of the Department of Epidemiology and Biostatistics at MSU; and Nigel Paneth, professor of epidemiology and biostatistics and pediatrics at MSU.

Using influenza infection and mortality data on Michigan from 1918-1920, Chandra identified four distinct waves. The first large peak was in March 1918. "After a second spike in cases in October 1918, the governor instituted a statewide ban on public gatherings," Chandra said. "Much like the restrictions that were put in place during the COVID-19 pandemic."

After three weeks, the number of cases decreased and the ban was lifted, which led to another peak in December 1918. "The ban didn't stop the spread of the flu. It just delayed the spike in cases," he said.

Chandra mapped the data showing the peaks and spikes in cases from October 1918 and December 1918 and tracked flu virus case growth by county over time. In October, counties in the southern part of the state and near the Mackinac Straits had the highest numbers but by December, the highest numbers of cases were in the heart of the state.

The most surprising piece of data came 18 months later in February 1920, when a statewide explosion of cases created a massive spike even larger than the one in October 1918. For Chandra, it is an educated guess as to the reasons for this delayed increase.

"Assuming it's the same influenza virus, World War I ended in 1918 and the men were coming home to their families," he said. "We had a mobile agent that brought the virus home to infect family members, which would explain the increase in cases among children and the elderly."

Unfortunately, there is not a way to confirm this, Chandra noted. "We would need samples from patients in 1920 from across the state. Then, we would need to compare those with samples from patients in 1918 from across the state, and that's not likely to happen."

The weather may have also been a factor since cool temperatures with low humidity likely provided optimal conditions for the virus to live and spread. Another factor that played a role was the absence of a vaccine.

"In 1918, there was no hope for a vaccine. In 2021, we have a vaccine available," he said.

One of the key insights from the 1918 pandemic that can inform the public health response to the 2020 COVID-19 pandemic is the number of people who are susceptible to the virus. Which means that it is possible that a spike like the February 1920 one will occur in late 2021 or early 2022.

"So many people will remain susceptible until they get vaccinated," Chandra said. "Bad things can still happen a year or two from now even if we see a decrease in the number of cases now. We still have over 200 million people walking around who are susceptible to the virus, including myself."

Credit: 
Michigan State University

Researchers explore how to protect gut integrity to improve outcomes in blood cancers

image: A new discovery in Dr. Xue-Zhong Yu's laboratory could potentially lead to a safer and more effective treatment option for graft-versus-host disease.

Image: 
MUSC Hollings Cancer Center

MUSC Hollings Cancer Center researchers found that a single strain of bacteria may be able to reduce the severity of graft-versus-host disease (GVHD), as reported online in February 2021 in JCI Insight.

Bone marrow transplant can be a lifesaving procedure for patients with blood cancers. However, GVHD is a potentially fatal side effect of transplantation, and it has limited treatment options. This proof-of-concept study demonstrates that better treatment options may be on the horizon for patients with GVHD.

Xue-Zhong Yu, M.D., associate director of Basic Science at Hollings Cancer Center, and lead author Hanief Sofi, Ph.D., realized that protecting the health of the gastrointestinal tract is a good target for reducing severe GVHD.

"If we can figure out how to keep a patient's intestinal tissue healthy before and after bone marrow transplant, then the patient's outcome will be much better. We know that restoring the microbiota diversity in the gut is an effective solution, but that comes with many challenges," said Yu.

Patients with blood cancers, such as leukemia, must undergo radiation and chemotherapy before they can get their new cancer-free immune system through bone marrow transplantation. The balance between the immune system and intestinal microbiota, communities of microorganisms that live in the gut, is especially important for proper intestinal health. Unfortunately, the radiation and chemotherapy radically throw off this balance, and the diversity of the microbiota is reduced 100- or even 1,000-fold. This leads to a condition called "leaky gut."

Clinical studies have shown that patients who recover microbiota diversity faster have better outcomes and less severe GVHD. Reduced microbiota diversity is associated with more severe GVHD.

Other studies have shown that fecal microbial transplantation (FMT) can be effective at reducing GVHD, but the challenge is how to get the right donor. Patients are heavily immune-deficient after bone marrow transplantation, and there is a great risk of bad infection if FMT is used in humans.

The Yu laboratory used two different strains of mice to establish a GVHD model that closely resembles the biology that occurs in humans after bone marrow transplantation. The mice developed acute GVHD. FMT significantly reduced acute GVHD in this model and reduced donor T cell proliferation in the organs, which is what triggers GVHD.

The researchers then used genetic sequencing to see which bacteria strains were most different between the fecal material of GVHD mice that received FMT and those that did not receive FMT.

Mice that had the best outcome, the lowest GVHD, had the highest levels of a bacteria called B. fragilis. Mice given this single bacterial strain had significantly reduced acute and chronic (long-term) GVHD compared to mice that did not get B. fragilis. In fact, B. fragilis alone was as good or even better than FMT.

Administration of B. fragilis increased overall gut microbial diversity, including increasing the amount of other beneficial bacteria strains. Surprisingly, GVHD was reduced in this model not only by live bacteria but also by bacteria that had been killed by short exposure to high heat.

The observation that B. fragilis was the main effective bacteria in the FMT process was not entirely new: B. fragilis also reduces autoimmunity in type 1 diabetes and colitis.

The current study by Yu and colleagues has two important findings. First, a molecule called polysaccharide A on the surface of B. fragilis appears to be critical for the GVHD-reducing functions of this bacteria. When the bacteria were modified to lack polysaccharide A, GVHD was not reduced compared to mice that did not receive any B. fragilis.

Secondly, the administration of B. fragilis did not reduce the graft-versus-leukemia or cancer-killing effect of the bone marrow transplantation, even though it did reduce donor T cell expansion in the gut. This is critical, since GVHD treatment options that reduce the graft-versus-leukemia effect would not be clinically significant.

"If this can be translated into the clinic, it would be a safer, easier and more effective treatment option," said Yu.

Further study in humans is needed to get this potential treatment into the clinic. Hematopoietic stem cells, given via bone marrow transplant, are classic immunotherapies for liquid tumors, but strategies to make the transplantation safer and more beneficial are sorely needed. Hollings Cancer Center researchers continue to search for the most effective therapies to improve patient outcomes and quality of life, he said.

Credit: 
Medical University of South Carolina

New improved dog reference genome will aid a new generation of investigation

Researchers at Uppsala University and the Swedish University of Agricultural Sciences have used new methods for DNA sequencing and annotation to build a new, and more complete, dog reference genome. This tool will serve as the foundation for a new era of research, helping scientists to better understand the link between DNA and disease, in dogs and in their human friends. The research is presented in the journal Communications Biology.

The dog has been aiding our understanding of the human genome since both genomes were released in the early 2000s. At that time, a comparison of both genomes, and two others, revealed that the human genome contained circa 20,000 genes, down from the around 100,000 predicted earlier. In the new study, researchers led by Dr Jennifer Meadows and Professor Kerstin Lindblad-Toh, have greatly improved the dog genome, identifying missing genes and highlighting regions of the genome that regulate when these genes are on or off.

A key factor was the move from short- to long-read technology, reducing the number of genome gaps from over 23,000 to a mere 585.

"We can think of the genome as a book," says Meadows. "In the previous assembly, many words and sometimes whole sentences were in the wrong order or even missing. Long-read technology allowed us to read whole paragraphs at once, greatly improving our comprehension of the genome."

"Additional tools which measure the DNA's 3D structure allowed us to place the paragraphs in order," adds Dr Chao Wang, first author of the study.

A better reference genome also helps disease research. Domestic dogs have lived alongside humans for tens of thousands of years and suffer from similar diseases to humans, including neurological and immunological diseases as well as cancer. Studying dog disease genetics can provide precise clues to the causes of corresponding human diseases.

"The improved canine genome assembly will be of great importance and use in canine comparative medicine, where we study diseases in dogs, for example osteosarcoma, systemic lupus erythematosus (SLE) and amyotrophic lateral sclerosis (ALS), with the goal of helping both canine and human health," says Lindblad-Toh.

Credit: 
Uppsala University

Lipid epoxides target pain, inflammatory pathways in neurons

image: Comparative biosciences professor Aditi Das led a study of modified lipids that target the body's endocannabinoid system, which is involved in regulating pain and inflammation.

Image: 
Photo by L. Brian Stauffer

CHAMPAIGN, Ill. -- When modified using a process known as epoxidation, two naturally occurring lipids are converted into potent agents that target multiple cannabinoid receptors in neurons, interrupting pathways that promote pain and inflammation, researchers report. These modified compounds, called epo-NA5HT and epo-NADA, have much more powerful effects than the molecules from which they are derived, which also regulate pain and inflammation.

Reported in the journal Nature Communications, the study opens a new avenue of research in the effort to find alternatives to potentially addictive opioid pain killers, researchers say.

The work is part of a long-term effort to understand the potentially therapeutic byproducts of lipid metabolism, a largely neglected area of research, said University of Illinois Urbana-Champaign comparative biosciences professor Aditi Das, who led the study. While many people appreciate the role of dietary lipids such as omega-3 and omega-6 fatty acids in promoting health, the body converts these fat-based nutrients into other forms, some of which also play a role in the healthy function of cells, tissues and organ systems.

"Our bodies use a lot of genes for lipid metabolism, and people don't know what these lipids do," said Das, also an affiliate of the Beckman Institute for Advanced Science and Technology and of the Cancer Center at Illinois. "When we consume things like polyunsaturated fatty acids, within a few hours they are transformed into lipid metabolites in the body."

Scientists tend to think of these molecules as metabolic byproducts, "but the body is using them for signaling processes," Das said. "I want to know the identity of those metabolites and figure out what they are doing."

She and her colleagues focused on the endocannabinoid system, as cannabinoid receptors on cells throughout the body play a role in regulating pain. When activated, cannabinoid receptors 1 and 2 tend to reduce pain and inflammation, while a third receptor, TRPV1, promotes the sensation of pain and contributes to inflammation. These receptors work together to modulate the body's responses to injury or disease.

"Understanding pain regulation in the body is important because we know we have an opioid crisis," Das said. "We're looking for lipid-based alternatives to opioids that can interact with the cannabinoid receptors and in the future be used to design therapeutics to reduce pain."

Previous research identified two lipid molecules, known as NA5HT and NADA, that naturally suppress pain and inflammation. Das and her colleagues discovered that brain cells possess the molecular machinery to epoxidize NA5HT and NADA, converting them to epo-NA5HT and epo-NADA. Further experiments revealed that these two epoxidated lipids are many times more potent than the precursor molecules in their interactions with the cannabinoid receptors.

"For example, we found that epo-NA5HT is a 30-fold stronger antagonist of TRPVI than NA5HT and displays a significantly stronger inhibition of TRPV1-mediated responses in neurons," Das said. It inhibits pathways associated with pain and inflammation, and promotes anti-inflammatory pathways.

The team was unable to determine whether neurons naturally epoxidate NA5HT and NADA in the brain, but the findings hold promise for the future development of lipid compounds that can combat pain and inflammation without the dangerous side effects associated with opioids, Das said.

Credit: 
University of Illinois at Urbana-Champaign, News Bureau

Discovery of a new law of phase separation

image: Researchers at The University of Tokyo discover a new law about how the complex network of phase-separated structures grows with time, which may lead to more efficient batteries and industrial catalysts

Image: 
Institute of Industrial Science, the University of Tokyo

Tokyo, Japan - Researchers from Institute of Industrial Science at The University of Tokyo investigated the mechanism of phase separation into the two phases with very different particle mobilities using computer simulations. They found that slow dynamics of complex connected networks control the rate of demixing, which can assist in the design of new functional porous materials, like lithium-ion batteries.

According to the old adage, oil and water don't mix. If you try to do it anyway, you will see the fascinating process of phase separation, in which the two immiscible liquids spontaneously "demix." In this case, the minority phase always forms droplets. Contrary to this, the researchers found that if one phase has much slower dynamics than the other phase, even the minority phase form complex networks instead of droplets. For example, in phase separation of colloidal suspensions (or protein solutions), the colloid-rich (or protein-rich) phase with slow dynamics forms a space-spanning network structure. The network structure thickens and coarsens with time while having the remarkable property of looking similar over a range of length scales, so the individual parts resemble the whole.

In the case of spontaneous demixing, the self-similar property causes the typical size of the domains to increase as a function of the elapsed time while obeying a power law. Classical theories predict that the growth exponent of the domains should be 1/3 and 1 for droplet or bicontinuous structures, respectively. However, for network-forming phase separation, it has not been explored how the structure grows or if there is such a law.

Now, using large-scale computer simulations, researchers at The University of Tokyo studied how the typical size of phase domains grows over time when a system is deeply quenched. "In such a situation, the particle mobility can be significantly different between the two phases, and then, the classical theory does not necessarily apply, " first author Michio Tateno says. The team studied the phase separation of a fluid into a gas and liquid and the demixing of a colloidal suspension consisting of insoluble particles and a liquid, using molecular dynamics simulations and hydrodynamic calculations, respectively. They found that the minority phase of slow dynamics universally forms a network structure that grows with a growth exponent of 1/2, and provided a theoretical explanation for the mechanism.

"Significant differences in the particle mobility between the two phases plays a critical role in controlling the speed of the demixing process," senior author Hajime Tanaka says. Because many devices, like rechargeable batteries and catalysts, rely on the creation of intricate porous networks, this research may lead to advances in these areas. In addition, it may shed light on certain cellular functions that have been hypothesized to be controlled by internal biological phase separations.

Credit: 
Institute of Industrial Science, The University of Tokyo

The chemistry lab inside cells

image: (A) X-ray crystal structure of QhpG and schematic of crosslinked QhpC. The substrate QhpC is bound to the pocket formed by the catalytic domain, which includes the FAD cofactor and the small domain. (B) QhpG-catalyzed dihydroxylation reaction.

Image: 
Osaka University

Osaka, Japan - Investigators from the Institute of Scientific and Industrial Research at Osaka University, together with Hiroshima Institute of Technology, have announced the discovery of a new protein that allows an organism to conduct an initial and essential step in converting amino acid residues on a crosslinked polypeptide into an enzyme cofactor. This research may lead to a better understanding of the biochemistry underlying catalysis in cells.

Every living cell is constantly pulsing with an array of biochemical reactions. The rates of these reactions are controlled by special proteins called enzymes, which catalyze specific processes that would otherwise take much longer. A number of enzymes require specialized molecules called "cofactors," which can help shuttle electrons back and forth during oxidation-reduction reactions. But these cofactors themselves must be produced by the organisms, and often require the assistance of previously existing proteins.

Now, a team of scientists at Osaka University has identified a novel protein called QhpG that is essential for the biogenesis of the enzyme cofactor cysteine tryptophylquinone (CTQ). By analyzing the mass of the reaction products and determining its crystal structure, they were able to deduce the catalytic function of QhpG, which is adding two hydroxyl groups to a specific tryptophan residue within an active-site subunit QhpC of quinoheme protein amine dehydrogenase, the bacterial enzyme catalyzing the oxidation of various primary amines. The resulting dihydroxylated tryptophan and an adjacent cysteine residue are finally converted to cofactor CTQ.

However, the action of QhpG is somewhat unusual compared with other protein-modifying enzymes in that it reacts with the tryptophan residue on the QhC triply crosslinked by another enzyme QhpD in a process call post-translation modification. Tryptophan, which naturally contains rings with conjugated bonds, needs the fewest changes to become a quinone cofactor. "Although several enzymes are known to contain a quinone cofactor derived from a tryptophan residue, the mechanism involved in post-translational modification, as well as the structures of the enzymes involved in their biogenesis, remains poorly understood," lead author Toshinori Oozeki says.

The proteins were obtained by introducing plasmids with the corresponding genes into E. coli bacteria and made into crystals. X-ray diffraction data of the crystal can determine the QhpG protein structure. The team then used computer software to simulate the docking of the target molecules, the triply crosslinked polypeptide QhpC, based on the crystal structure they found for QhpG. The two post-translational modifications of QhpC are successively carried out in the modification enzyme complex QhpD-QhpG. "Our findings can be applied to development of novel bioactive peptides using enzymes that modify amino acids," senior author Toshihide Okajima says. Some of these applications include creating new enzymes for the bioremediation of toxic chemicals.

Credit: 
Osaka University

Virtual post-sepsis recovery program may also help recovering COVID-19 patients

image: Post-sepsis model may help COVID-19 patients after discharge.

Image: 
ATS

Feb. 10, 2021 - A new paper published online in the Annals of the American Thoracic Society describes a "virtual" recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses.

In "Translating Post-Sepsis Care to Post-COVID Care: The Case for a Virtual Recovery Program," Stephanie Parks Taylor, MD, Department of Internal Medicine, Atrium Health, Charlotte, North Carolina, and co-authors describe a model of virtual care they developed and successfully implemented for patients who have left the hospital after being treated for sepsis. They also address ways that this model of care may help severe COVID-19 patients who have survived their illness but need continuing care.

"Our initial health services research indicated that recommended post-sepsis care practices were inconsistently applied for sepsis survivors, but the application of these practices was associated with fewer rehospitalizations and deaths at 90 days post-discharge," said Dr. Taylor. "We decided to engage a multidisciplinary stakeholder group to develop a mechanism to deliver best-practice post-sepsis care. Given the challenges many patients experience returning for face-to-face visits after critical illness, the virtual transition program emerged as an ideal approach that combined quality, patient-centeredness and scalability."

This multicomponent sepsis transition and recovery program, known as "STAR," is conducted virtually by a specialized nurse navigator, who provides best-practice care for high-risk sepsis survivors post-hospital discharge. The nurse navigator helps deliver care through low-technology telehealth methods, including electronic health records (EHRs), secure messaging services and telephone. The sepsis nurse navigators monitor and support patients from a centralized, geographically distant location.

"While there is still a lot to learn about COVID-19 survivorship, based on what we currently know we can assume COVID survivors experience many of the same issues as recovering sepsis patients," said Dr. Taylor. "The STAR program leverages a virtual platform that addresses the challenges of care delivery in a pandemic setting."

According to Dr. Taylor, these challenges include strain on the health care system due to a rapid surge in survivors and reduced access to traditional primary care follow-up due to physical distancing.

Dr. Taylor and colleagues cite a number of factors that they have found important to successfully implementing their program:

Adequate human, financial and technological resources. Upfront funding and adequate training for the navigators are critical for success. Navigators should be trained in a number of areas, such as sepsis education, communication skills and cultural awareness.

A method to identify high-risk patients. The team developed and deployed a data-driven, EHR-embedded algorithm and risk models to identify patients at high risk of post-discharge death or rehospitalization.

Robust and effective operational processes. Among the additional elements that should be part of the program's operation are: optimization of medications, including frequent reassessment and adjustment of dosages; screening and early intervention for functional, cognitive and mental health problems, which are common among sepsis survivors and appear to be even worse for COVID-19 survivors; symptom monitoring to ensure that new infections do not occur, and to look for signs that other pre-existing conditions are worsening (such as weight gain for heart failure patients) or indications of adverse drug reactions (such as bleeding for patients receiving anticoagulants), and establishing goals of care, in partnership with patients, and communicating this information to the patient's primary care physician. STAR navigators are supported by a hospital-based physician (hospitalist) who reviews cases and discusses issues that arise.

Dr. Taylor notes that Atrium Health is an integrated health system, and that home health or community paramedicine providers can be activated for evaluation or treatment in patients' homes. "Whether the implementing site is an integrated health system or not, programs will need to establish robust communication pathways for efficient exchange of information between navigators and relevant partners," she said. "I think a potential misstep could be implementing a transition program that identifies problems among sepsis survivors but lacks an efficient process for responding effectively to those problems."

Additionally, much of the home care and some of the post-acute skilled nursing facilities are integrated within the health system, but many are not. Dr. Taylor and co-author Marc A. Kowalkowski, PhD, are now studying how to overcome barriers to providing extra support to post-acute care settings, as these patients are particularly vulnerable after hospital discharge.

The authors add that there are a number of advantages of a virtual navigator platform for sepsis transition and recovery:

Improved access and adherence to follow-up. This type of program can help ensure sepsis survivors get follow-up care, which is frequently not provided or easily accessible. It may also reduce rural, socioeconomic and disability disparities.

Frequent reassessment and adjustment of patients' care plan. This is made possible by virtual visits with nurse navigators, who can provide long-term follow up at short intervals. The STAR navigator program continues for 90 days after hospital discharge, and patients with persistent challenges have the most frequent navigator contact.

Consistent "check-ins" from a familiar health professional may have psychological benefits. The nurse navigator can help alleviate the stress disorders that are common among sepsis survivors.

The program is cost-effective and scalable. This model of care delivery enables one STAR navigator to accept 20-30 new patients a month and provide 90 days of support.

Dr. Taylor concludes, "Since severe COVID can be considered a type of sepsis, COVID patients are entering the STAR program if they meet its eligibility criteria. Currently, post-COVID patients are receiving the same elements of care as sepsis survivors, with special attention to respiratory symptoms and associated complications. Part of our research involves evaluating the extent to which post-COVID recovery differs from non-COVID sepsis recovery, so we hope to have data to determine whether there will be factors that are unique to COVID survivorship."

Credit: 
American Thoracic Society

Industrial compound gets eco-friendly reaction

image: Sodium or magnesium aryloxides can catalyse the transesterification of methyl (meth)acrylate at room temperature, with high chemoselectivity, producing a high yield of (meth)acrylate ester, and without the use of toxic metals or ligands.

Image: 
Kazuaki Ishihara

Nagoya University scientists have developed a chemical reaction that produces high yields of a compound used in a wide variety of industries, without needing high temperatures or toxic catalysts. The approach was described in the journal ACS Catalysis and offers a practical and sustainable solution for industrial (meth)acrylate (= acrylate or methacrylate) ester synthesis.

(Meth)acrylate esters are used in industrial coatings and masonry, and to make plastics, dyes and adhesives. But the chemical process for making them from methyl (meth)acrylates involves high temperatures, long reaction times and toxic compounds. It can also result in unwanted side reactions.

Scientists, including Nagoya University professor Kazuaki Ishihara and colleagues, have been working on improving this process to make it more eco-friendly. Specifically, they worked on improving the catalyst involved in the chemical reaction that turns methyl (meth)acrylates into (meth)acrylate esters, called transesterification.

"Millions of tons of (meth)acrylate esters are produced annually and are among the most important manufactured chemicals around," says Ishihara. "Their transesterification, using alcohol and a catalyst, fine-tunes their properties, producing a wide range of (meth)acrylate esters."

Ishihara and his colleagues found that sterically bulky sodium and magnesium aryloxides worked very well as non-toxic alternatives. They catalysed the transesterification of methyl (meth)acrylates at the relatively mild temperature of 25°C, producing high yields of a broad range of (meth)acrylate esters depending on the type of alcohol used in the reaction.

The team also conducted computational calculations to uncover the details of what happened during the chemical reaction, showing that it had high chemoselectivity; in other words, the reaction happened the way the scientists wanted it to without having undesirable side reactions.

"Our transesterification process is a practical and sustainable candidate for industrial (meth)acrylate ester synthesis, providing excellent chemoselectivity, high yields, mild reaction conditions and a lack of any toxic metal salts," says Ishihara.

The team next aims to collaborate with colleagues in industry to use their approach in (meth)acrylate ester production. They also aim to continue searching for efficient catalysts for the transesterification of methyl (meth)acrylates and to develop recyclable catalysts.

Credit: 
Nagoya University

Sleep keeps teens on track for good mental health

image: Teenagers need at least eight hours of sleep each night.

Image: 
Kinga Cichewicz

As families settle back into a new school year, sleep experts at the University of South Australia are reminding parents about the importance of teenagers getting enough sleep, cautioning them that insufficient sleep can negatively affect their mental health.

In a new research paper, UniSA sleep experts Dr Alex Agostini and Dr Stephanie Centofanti confirm that sleep is intrinsically linked to mental health, but is commonly overlooked by health practitioners as a contributing factor.

Dr Agostini says it's imperative that parents and medical practitioners are aware of the bi-directional relationship between sleep and mental health, particularly across the teenage years.

"Getting enough sleep is important for all of us ¬¬- it helps our physical and mental health, boosts our immunity, and ensures we can function well on a daily basis," Dr Agostini¬ says.

"But for teenagers, sleep is especially critical because they're at an age where they're going through a whole range of physical, social, and developmental changes, all of which depend on enough sleep.

"Research shows that teenagers need at least eight hours of sleep each night. Without this, they're less able to deal with stressors, such as bullying or social pressures, and run the risk of developing behavioural problems, as well as anxiety and depression.

"If sleep drops to less than six hours a night, research shows that teens are twice as likely to engage in risky behaviours such as dangerous driving, marijuana, alcohol or tobacco use, risky sexual behaviour, and other aggressive or harmful activities."

In Australia, almost one in seven children and adolescents (aged 4-17 years) will experience a mental health disorder. The World Health Organization says that while half of all mental health conditions start by age 14, most cases go undetected and untreated.

Co-researcher, Dr Centofanti says while many factors contribute to later bedtimes for teenagers, technology is one of the greatest offenders.

"Teens spend a lot of time on devices, whether it's texting friends, playing games, or watching videos, using technology late into the night is one of the most common disruptors of good sleep. Overuse of technology can also contribute to mental health issues likely to increase anxiety," Dr Centofanti says.

"Not only can technology use make us feel anxious and awake, but the blue light emitted from technology inhibits the production of the sleep hormone melatonin to delay the natural onset of sleep. This is problematic because teens already have a biological tendency to want to stay up late and sleep in.

"To make a real difference to teenage mental health, both parents and medical practitioners must understand how sleep can affect mental health in teenagers."

Credit: 
University of South Australia